News | August 06, 2024
Indraprastha Medical Corporation posts Q1 FY25 PAT at Rs. 44.77 Cr
Indraprastha Medical Corporation has reported total income of Rs. 352.98 crores during the quarter ended June 30, 2024
Indraprastha Medical Corporation has reported total income of Rs. 352.98 crores during the quarter ended June 30, 2024
Themis Medicare has reported total income of Rs. 123.95 crores during the period ended June 30, 2024
Decision on EU marketing authorisation for this population expected by September 2024
GSK and Flagship to jointly fund up to $150 million upfront
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
Poly Medicure has reported total income of Rs. 401.69 crores during the period ended June 30, 2024
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Subscribe To Our Newsletter & Stay Updated
